COMPANY OVERVIEW ($CYTO.V)

Cytophage Technologies (TSXV:CYTO) is a pioneering biotechnology company dedicated to bacteriophage research, product development and commercialization.

Committed to addressing the global challenge of antibiotic resistance, Cytophage advances innovative products that harness the power of bacteriophages to combat bacterial infections affecting human health, animal health, and food security.

Stock Information

Shares Outstanding
53,753,346
Warrants

7,114,165

Options

5,188,875

Fully Diluted

66,045,386

Investment Highlights

  • Pioneers in bacteriophage solutions
  • First publicly listed bacteriophage company with a stated focus on both animal health and human health solutions
  • Diversified pipeline of near term commercial sales
  • De-risked, replicable technology
  • Strong leadership team combining experience in high profile research, finance and commercialization

Cytophage in the news

MEDIA - WINNIPEG FREE PRESS

‘Space to expand’ antibacterial front line: Bioscience business Cytophage takes over former trampoline park building

The only people bouncing around a former Winnipeg area trampoline park will be scientists in lab coats. Bioscience business Cytophage is quadrupling its footprint by moving to the former Sky Zone location in the Rural Municipality of Macdonald.

Read More

NEWS RELEASE

Cytophage Announces Fiscal Year End 2023 Results

Winnipeg, April 30, 2024. Cytophage Technologies Ltd. (TSXV:CYTO) (“Cytophage” or the “Company”), the only publicly traded phage company that is focused on bacteriophage solutions for both animal health and human health, today released its fiscal year end results for the year ending December 31st, 2023.

Read More

NEWS RELEASE

Cytophage Appoints New Board Director

Winnipeg, April 16, 2024. Cytophage Technologies Ltd. (TSXV:CYTO) (“Cytophage” or the “Company”) is pleased to announce that Michael D. Cochrane, a managing partner at Dixford Capital, LLC, has joined the Cytophage board of directors as its newest member.

Read More

Subscribe For Investor Alerts

CORPORATE PRESENTATION

Investor Contact Information

We can win the war against battlefield infection.
Cytophage was selected for the Defense Innovation Award 2019.

Winner of 2018 Nutreco Feed Tech Challenge
For our breakthrough innovation to help feed the world.

Swine Bacteriophage

We’re helping farmers meet the need and the demand for a healthier food chain.

Funded in part by the Canada and Manitoba governments through the Canadian Agricultural Partnership – Ag Action Manitoba Program. Learn more

Contact Us

Learn more about our bacteriophage solutions.

Cytophage Technologies Ltd. © 2019